Risk Factors and Outcomes of Bloodstream Infections Among People With Human Immunodeficiency Virus: A Longitudinal Cohort Study From 2000 to 2017
- PMID: 35937645
- PMCID: PMC9346145
- DOI: 10.1093/ofid/ofac318
Risk Factors and Outcomes of Bloodstream Infections Among People With Human Immunodeficiency Virus: A Longitudinal Cohort Study From 2000 to 2017
Abstract
Background: Bloodstream infections (BSIs) among people with human immunodeficiency virus (PWH) remain a poorly studied source of morbidity and mortality. We characterize the epidemiology, microbiology, and clinical outcomes including reinfection, hospitalization, and mortality rates of both community-acquired and hospital-acquired BSI in PWH.
Methods: We identified all BSI, between January 1, 2000 and December 31, 2017 in PWH in care at Southern Alberta Clinic, by linking data from laboratory and clinical databases. Crude incidence rates per 1000 person-years for BSI and death were calculated. Cox proportional hazards models estimated crude and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) to conduct a risk factor analysis of BSI in PWH. Logistic regression models with generalized estimating equations estimated crude and adjusted odds ratios (aORs) to identify characteristics associated with 1-year mortality after BSI.
Results: Among 2895 PWH, 396 BSI episodes occurred in 228 (8%) PWH. There were 278 (72%) Gram-positive and 109 (28%) Gram-negative BSI. People with human immunodeficiency virus with lower CD4 nadirs, higher Charlson comorbidity indices, and hepatitis C virus were at highest risk for BSI. Long-term all-cause mortality was greater in those experiencing BSI (HR, 5.25; 95% CI, 4.21-6.55). CD4 count <200 cells/mm3 measured closest to the time of BSI was associated with 1-year mortality after BSI (aOR, 3.88; 95% CI, 1.78-8.46). Repeat episodes (42%) and polymicrobial BSI (19%) were common.
Conclusions: Bloodstream infections continue to occur at an elevated rate among PWH with high reoccurrence rates and associated morbidity and mortality. To risk stratify and develop targeted interventions, we identified PWH at greatest risk for BSI. People with human immunodeficiency virus with low immunity at the time of BSI are at highest risk of poor outcomes.
Keywords: Canada; HIV/AIDS; bacteremia; bloodstream infection; longitudinal.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures



Similar articles
-
Neurologic infections in people with HIV: shifting epidemiological and clinical patterns.AIDS. 2024 Jan 1;38(1):49-58. doi: 10.1097/QAD.0000000000003723. Epub 2023 Sep 11. AIDS. 2024. PMID: 37702419
-
Longitudinal evaluation of risk factors and outcomes of blood stream infections due to Staphylococcus species in persons with HIV: An observational cohort study.EClinicalMedicine. 2020 Dec 5;31:100675. doi: 10.1016/j.eclinm.2020.100675. eCollection 2021 Jan. EClinicalMedicine. 2020. PMID: 33554080 Free PMC article.
-
Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study.J Glob Antimicrob Resist. 2019 Sep;18:139-144. doi: 10.1016/j.jgar.2019.02.014. Epub 2019 Feb 27. J Glob Antimicrob Resist. 2019. PMID: 30825701
-
Matched case-control analysis of polymicrobial bloodstream infection in a neonatal intensive care unit.Infect Control Hosp Epidemiol. 2008 Oct;29(10):914-20. doi: 10.1086/591323. Infect Control Hosp Epidemiol. 2008. PMID: 18808341
-
Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality.Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):969-76. doi: 10.1007/s10096-008-0531-5. Epub 2008 May 1. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18449581
Cited by
-
Antibiotic Prescriptions in Critically Ill Patients with Bloodstream Infection Due to ESBL-Producing Enterobacteriaceae: Compliance with the French Guidelines for the Treatment of Infections with Third-Generation Cephalosporin-Resistant Enterobacteriaceae-A Multicentric Retrospective Cohort Study.Microorganisms. 2023 Oct 31;11(11):2676. doi: 10.3390/microorganisms11112676. Microorganisms. 2023. PMID: 38004688 Free PMC article.
References
-
- Hanhoff N, Vu Q, Lang R, et al. . Impact of three decades of antiretroviral therapy in a longitudinal population cohort study. Antivir Ther 2019; 24:153–65. - PubMed
-
- Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 2000; 117:1017–22. - PubMed
-
- Huson MA, Stolp SM, van der Poll T, Grobusch MP. Community-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review. Clin Infect Dis 2014; 58:79–92. - PubMed
-
- Declercq S, De Munter P, Derdelinckx I, et al. . Characteristics, causes, and outcome of 54 episodes of bloodstream infections in a cohort of HIV patients. Infect Dis (Lond) 2015; 47:611–7. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials